115 related articles for article (PubMed ID: 10897231)
41. Urinary tract infection. Diabetics and non-diabetic patients.
Akbar DH
Saudi Med J; 2001 Apr; 22(4):326-9. PubMed ID: 11331489
[TBL] [Abstract][Full Text] [Related]
42. Risk factors for antibiotic-resistant Escherichia coli isolated from hospitalized patients with urinary tract infections: a prospective study.
Sotto A; De Boever CM; Fabbro-Peray P; Gouby A; Sirot D; Jourdan J
J Clin Microbiol; 2001 Feb; 39(2):438-44. PubMed ID: 11158087
[TBL] [Abstract][Full Text] [Related]
43. Susceptibility of antimicrobial-resistant urinary Escherichia coli isolates to fluoroquinolones and nitrofurantoin.
Karlowsky JA; Thornsberry C; Jones ME; Sahm DF
Clin Infect Dis; 2003 Jan; 36(2):183-7. PubMed ID: 12522750
[TBL] [Abstract][Full Text] [Related]
44. Causative agents and antimicrobial susceptibilities of urinary tract infections in the northwest of Iran.
Farajnia S; Alikhani MY; Ghotaslou R; Naghili B; Nakhlband A
Int J Infect Dis; 2009 Mar; 13(2):140-4. PubMed ID: 18703368
[TBL] [Abstract][Full Text] [Related]
45. [Antimicrobial susceptibility of organisms infecting the urinary tract in northern Israel].
Oren B; Raz R; Hefter H; Kennes Y; Potasman I
Harefuah; 1991 Jan; 120(2):60-2. PubMed ID: 2007488
[TBL] [Abstract][Full Text] [Related]
46. Prevalence and predictors of trimethoprim-sulfamethoxazole resistance among uropathogenic Escherichia coli isolates in Michigan.
Brown PD; Freeman A; Foxman B
Clin Infect Dis; 2002 Apr; 34(8):1061-6. PubMed ID: 11914994
[TBL] [Abstract][Full Text] [Related]
47. [Microbiology of urinary tract infections in ambulatory patients. Therapeutic options in times of high antibiotic resistance].
Arreguín V; Cebada M; Simón JI; Sifuentes-Osornio J; Bobadilla-del Valle M; Macías AE
Rev Invest Clin; 2007; 59(4):239-45. PubMed ID: 18019596
[TBL] [Abstract][Full Text] [Related]
48. Antibiotic resistance of coliform organisms from community-acquired urinary tract infections in Zenica-Doboj Canton, Bosnia and Herzegovina.
Uzunovic-Kamberovic S
J Antimicrob Chemother; 2006 Aug; 58(2):344-8. PubMed ID: 16775214
[TBL] [Abstract][Full Text] [Related]
49. Escherichia coli phylogenetic groups are associated with site of infection and level of antibiotic resistance in community-acquired bacteraemia: a 10 year population-based study in Denmark.
Bukh AS; Schønheyder HC; Emmersen JM; Søgaard M; Bastholm S; Roslev P
J Antimicrob Chemother; 2009 Jul; 64(1):163-8. PubMed ID: 19429665
[TBL] [Abstract][Full Text] [Related]
50. Urinary tract infection: traditional pharmacologic therapies.
Nicolle LE
Dis Mon; 2003 Feb; 49(2):111-28. PubMed ID: 12601341
[TBL] [Abstract][Full Text] [Related]
51. Improved antimicrobial susceptibility of community-acquired uropathogens in northern Israel (1995-1999-2002).
Chazan B; Sakran W; Raz R; Colodner R
Int J Antimicrob Agents; 2004 Jul; 24(1):89-92. PubMed ID: 15225869
[TBL] [Abstract][Full Text] [Related]
52. Epidemiology and clinical characteristics of patients with Staphylococcus saprophyticus bacteriuria in Israel.
Colodner R; Ken-Dror S; Kavenshtock B; Chazan B; Raz R
Infection; 2006 Oct; 34(5):278-81. PubMed ID: 17033753
[TBL] [Abstract][Full Text] [Related]
53. The ECO.SENS Project: a prospective, multinational, multicentre epidemiological survey of the prevalence and antimicrobial susceptibility of urinary tract pathogens--interim report.
Kahlmeter G
J Antimicrob Chemother; 2000 Sep; 46 Suppl 1():15-22; discussion 63-5. PubMed ID: 11051619
[TBL] [Abstract][Full Text] [Related]
54. Antimicrobial resistance among uropathogens that cause community-acquired urinary tract infections in women: a nationwide analysis.
Gupta K; Sahm DF; Mayfield D; Stamm WE
Clin Infect Dis; 2001 Jul; 33(1):89-94. PubMed ID: 11389500
[TBL] [Abstract][Full Text] [Related]
55. Uncomplicated E. coli urinary tract infection in college women: a follow-up study of E. coli sensitivities to commonly prescribed antibiotics.
Ansbach RK; Dybus K; Bergeson R
J Am Coll Health; 2005; 54(2):81-4; discussion 85-6. PubMed ID: 16255319
[TBL] [Abstract][Full Text] [Related]
56. Antimicrobial resistance of urinary isolates in the community and its relation to antibiotic use.
Raz R; Hefter H; Oren B; Kennes Y; Potasman I
Isr J Med Sci; 1993 Apr; 29(4):207-10. PubMed ID: 8491570
[No Abstract] [Full Text] [Related]
57. Asymptomatic bacteriuria in pregnancy: epidemiological, clinical and microbiological approach.
Gebre-Selassie S
Ethiop Med J; 1998 Jul; 36(3):185-92. PubMed ID: 10214459
[TBL] [Abstract][Full Text] [Related]
58. [Single-dose amoxicillin, TMP-SMX and ofloxacin therapy in lower urinary tract infections].
Unal S; Aydin M; Ozaydin N; Akin A
Mikrobiyol Bul; 1989 Jul; 23(3):231-7. PubMed ID: 2487463
[TBL] [Abstract][Full Text] [Related]
59. Risk factors for non-Escherichia coli community-acquired bacteriuria.
Amna MA; Chazan B; Raz R; Edelstein H; Colodner R
Infection; 2013 Apr; 41(2):473-7. PubMed ID: 23055152
[TBL] [Abstract][Full Text] [Related]
60. Urinary tract infections in children < 2 years of age hospitalized in a tertiary medical center in Southern Israel: epidemiologic, imaging, and microbiologic characteristics of first episode in life.
Shaki D; Hodik G; Elamour S; Nassar R; Kristal E; Leibovitz R; Horev A; Leibovitz E
Eur J Clin Microbiol Infect Dis; 2020 May; 39(5):955-963. PubMed ID: 31930442
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
